Candida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options

dc.contributorUniversidade Estadual de Campinas (UNICAMP)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2018-12-11T17:22:41Z
dc.date.available2018-12-11T17:22:41Z
dc.date.created2018-12-11T17:22:41Z
dc.date.issued2018-12-01
dc.identifierMicrobial Pathogenesis, v. 125, p. 116-121.
dc.identifier1096-1208
dc.identifier0882-4010
dc.identifierhttp://hdl.handle.net/11449/176832
dc.identifier10.1016/j.micpath.2018.09.014
dc.identifier2-s2.0-85053214625
dc.identifier2-s2.0-85053214625.pdf
dc.description.abstractCandida auris emerged as a pathogen resistant to multiple antifungal and has been associated with nosocomial outbreaks with high transmission capacity between hospitalized individuals. C. auris was first described in 2009, after being isolated from the external ear canal discharge of a patient in Japan. The difficulty in identification, incorrect use of antifungal drugs, and treatment failure are causes of high mortality. Since then, C. auris has been increasingly reported from East Asia to North America, with substantial fatalities and misidentification. This review aims at describing the epidemiology, virulence, risk factors, resistance, and therapeutic options in C. auris infections.
dc.languageeng
dc.relationMicrobial Pathogenesis
dc.relation0,751
dc.relation0,751
dc.rightsAcesso aberto
dc.sourceScopus
dc.subjectCandida auris
dc.subjectResistance
dc.subjectVirulence factor
dc.titleCandida auris: Epidemiology, risk factors, virulence, resistance, and therapeutic options
dc.typeOtros


Este ítem pertenece a la siguiente institución